FDA NDC Directory · JSON-LD · Markdown

LEXISCAN(R) (REGADENOSON)

NDC 51662-1448 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerHF Acquisition Co LLC, DBA HealthFirst
Marketing categoryNew Drug Application (innovator) · App NDA022161
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsREGADENOSON (.08 mg/mL)
Marketing started20191210
Package count1

External sources

Source: openFDA. Public-domain (CC0).